ERBC , a leading preclinical contract research organization ( CRO ), and Menarini Biotech , a Menarini Group company providing custom development and manufacturing (CDMO) services and specializing in the development and manufacturing...
Inmagene Biopharmaceuticals ("Inmagene") announces that the U.S. Food and Drug Administration (FDA) has cleared drug candidate IMG-007, a monoclonal antibody against OX40, to proceed...
The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac or recombinant Covid-19 vaccine (AstraZeneca/Fiocruz)
Also...
